Global Microarray Market

Global Microarray Market Size, Share, Growth Analysis, By Product & services(Consumable, Instruments), By Type(DNA Microarray, Protein Microarray), By End-user(Research and Academic Institutes, Pharmaceutical and Biotechnology Companies) - Industry Forecast 2024-2031


Report ID: SQMIG35A2595 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 91 | Figures: 76

Global Microarray Market Insights

Global Microarray Market size was valued at USD 3.9 billion in 2021 and is poised to grow from USD 4.53 billion in 2023 to USD 7.67 billion by 2030, at a CAGR of 7.8% during the forecast period (2023-2030).

Microarray technology involves the binding of many nucleic acids to a surface, enabling the measurement of relative concentrations of nucleic acid sequences through hybridization and subsequent detection.

It is widely used for quantifying gene expression levels and identifying transcription factor binding sites when combined with chromatin immunoprecipitation. Microarrays were one of the earliest technologies that provided biologists with vast amounts of complex digital data, except for DNA sequencing.

The availability of raw and processed data allows for further analysis and meta-analyses beyond the scope of the original data producers. To ensure reproducible science and facilitate data exchange, the Function Genomics Data Society developed the MIAME (Minimum Information About a Microarray Experiment) standards for describing microarray experiments. These standards aim to enhance the quality and consistency of reporting in microarray research. These factors will drive its demand during the forecast period.

Market snapshot - 2024-2031

Global Market Size

USD 3.9 billion

Largest Segment

DNA

Fastest Growth

DNA

Growth Rate

7.8% CAGR

Global Microarray Analysis Market ($ Bn)
Country Share for North America Region (%)
Global Microarray Analysis Market By Type ($ Bn)
Global Microarray Analysis Market By Type (%)

To get more reports on the above market click here to Buy The Report

Global Microarray Market Segmental Analysis

The microarray market is categorized into product & services, type, region, and end user. In terms of product & services, it includes consumables, instruments, software, and services. The consumables segment further encompasses research applications, drug discovery, disease diagnostics, and other applications. Similarly, the instruments segment and software and services segment are also sub-classified into various applications. In terms of Type, the market includes DNA microarray, protein microarray, and other microarrays. The market is also segmented by End User, which consists of research and academic institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA regions, covering major countries within each region.

Analysis By Product & services

The consumable segment is expected to dominate the microarray market during the forecast period. This can be attributed to several factors that contribute to its growth. Firstly, there has been a significant increase in ongoing research and development (R&D) activities across various industries, including pharmaceuticals, biotechnology, and genomics. Microarrays play a crucial role in these activities by enabling the simultaneous analysis of a large number of nucleic acid sequences, allowing researchers to obtain valuable insights into gene expression patterns, genetic variations, and disease mechanisms.

Additionally, governments around the world have been providing substantial support for R&D expenditure, particularly in the healthcare and life sciences sectors. This support has fueled the adoption of microarray technology, leading to increased demand for consumable products such as microarray chips, probes, reagents, and other related materials.

Analysis By Type

The DNA microarray segment is expected to hold the largest share in the microarray market during the forecast period. This can be attributed to several factors that contribute to its growth.

Firstly, there has been a significant increase in the number of DNA analyses being performed using microarray technology. DNA microarrays enable researchers to study gene expression patterns, genetic variations, and DNA-protein interactions on a large scale, providing valuable insights into various biological processes and diseases. The versatility and comprehensive nature of DNA microarrays make them highly desirable in research and diagnostics. Furthermore, there has been a surge in research expenditure specifically focused on DNA microarray analysis. The growing understanding of the human genome and its impact on health and disease has fueled the need for advanced DNA analysis tools like microarrays.

Analysis by End-use

This segment encompasses various end users beyond the specified categories such as research and academic institutions, pharmaceutical and biotechnology companies, and diagnostic laboratories.

One of the key factors driving the growth of the "other end users" segment is the increase in the number of research institutions. These institutions, including government-funded research organizations and non-profit research centers, are actively engaged in scientific studies across diverse fields. The demand for microarray technology from these institutions is driven by the need for advanced tools to support their research efforts. Furthermore, the growing target geriatric population has contributed to the demand for microarray analysis. As the elderly population increases, there is a greater focus on understanding age-related diseases and genetic factors that contribute to them. Microarray technology provides valuable insights into genetic variations and gene expression patterns associated with these conditions, aiding in research and potential therapeutic developments.

Global Microarray Analysis Market By Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Microarray Market Regional Insights

In 2021, North America emerged as the leading region in terms of revenue share in the microarray market, and this dominance is expected to persist until 2031. Several factors contribute to North America's continued prominence in the market. Firstly, the region benefits from a large patient population, which drives the demand for advanced diagnostic and research tools like microarray technology.

Additionally, North America boasts a strong presence of key players in the microarray market. These established companies have a wide product portfolio and distribution networks, ensuring easy availability of microarray products throughout the region. The well-developed healthcare infrastructure in North America further supports the adoption and utilization of microarray technology.

Global Microarray Analysis Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Microarray Market Dynamics

Advancements in Genomic Research to Bolster Market Growth

  • The continuous advancements in genomic research and the increasing understanding of the genetic basis of diseases have fueled the demand for microarray technology. Microarrays enable researchers to analyze large sets of genetic information simultaneously, facilitating the identification of disease markers, gene expression patterns, and potential therapeutic targets.
  • Microarrays play a crucial role in personalized medicine by allowing for the analysis of an individual's genetic information to guide treatment decisions. The increasing focus on precision medicine and targeted therapies has driven the adoption of microarray technology in clinical settings. It enables the identification of specific genetic variations and biomarkers that can inform personalized treatment approaches, leading to improved patient outcomes.

High Cost and Complexity of Data Analysis to Hinder Market

  • Microarray technology can be expensive, particularly for high-density arrays and custom designs. The cost of microarray platforms, reagents, and analysis tools can limit their adoption, especially for smaller research laboratories or resource-constrained settings.
  • Microarray data analysis involves processing and interpreting vast amounts of gene expression or genotyping data. It requires specialized bioinformatics expertise and computational resources, which may pose challenges for researchers or clinicians who lack the necessary skills or infrastructure.

Request Free Customization of this report to help us to meet your business objectives.

Global Microarray Market Competitive Landscape

The competitive landscape of the microarray market is characterized by the presence of several key players operating globally and regionally. These companies focus on product development, strategic collaborations, and acquisitions to strengthen their market position. These companies invest significantly in research and development to introduce innovative microarray solutions and expand their product portfolios. They also engage in strategic partnerships and collaborations with academic institutions, research organizations, and pharmaceutical companies to enhance their market presence. With the growing demand for advanced genomic technologies, companies in the microarray market are focusing on offering comprehensive solutions that provide accurate and reliable gene expression analysis, enabling researchers and clinicians to gain valuable insights into diseases and facilitate personalized medicine approaches.

Top Player’s Company Profiles

  • Merck KGaA (Germany)
  • PerkinElmer, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Qiagen N.V. (Netherlands)
  • GE Healthcare (United Kingdom)
  • Eurofins Scientific (Luxembourg)
  • Fluidigm Corporation (United States)
  • Oxford Gene Technology (United Kingdom)
  • Arrayit Corporation (United States)
  • Applied Micro Arrays (United States)
  • Phalanx Biotech Group (Taiwan)
  • LC Sciences (United States)
  • Savyon Diagnostics (Israel)
  • Progenika Biopharma (Spain)
  • Illuminomics Corporation (United States)
  • Sengenics (Singapore)

Recent Developments

  • In 2021, Illumina, Inc., a leading provider of microarray and sequencing technologies, announced the launch of its new microarray platform called the Infinium™ MethylationEPIC BeadChip. This platform enables high-throughput analysis of DNA methylation patterns, offering researchers a comprehensive tool for studying epigenetic modifications associated with various diseases and biological processes. The MethylationEPIC BeadChip provides enhanced coverage of genomic regions, including regulatory elements and CpG islands, and offers high data quality and reproducibility.

Global Microarray Key Market Trends

  • The microarray market is witnessing several key market trends. Firstly, there is a growing demand for personalized medicine and precision diagnostics, which is driving the adoption of microarray technology for genetic analysis and profiling. This is fueled by advancements in genomics research and an increasing understanding of the role of genetic variations in disease susceptibility and treatment response. Secondly, there is a shift towards multiplexing and high-throughput analysis, with the development of microarrays capable of simultaneously analyzing thousands of genes or proteins. This enables researchers to obtain comprehensive data in a more efficient and cost-effective manner. Additionally, there is a rising focus on biomarker discovery and validation, as microarrays are being utilized to identify and validate potential biomarkers for various diseases, aiding in early detection and targeted therapies.

Global Microarray Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the microarray market is expected to witness significant growth in the future due to several factors. Technological advancements and innovations in microarray platforms, such as the development of high-density arrays and improved sensitivity, are enhancing the performance and accuracy of microarray analysis. The increasing demand for personalized medicine, precision diagnostics, and biomarker discovery is driving the adoption of microarray technology in research, clinical diagnostics, and pharmaceutical industries. Additionally, the expanding applications of microarrays in genomics, proteomics, and epigenomics research, along with the rising investment in genomic research, are expected to fuel the growth of the microarray market in the coming years.

Report Metric Details
Market size value in 2023 USD 3.9 billion
Market size value in 2031 USD 7.67 billion
Growth Rate 7.8%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product & services
    • Consumable, Instruments, Software and Services
  • Type
    • DNA Microarray, Protein Microarray, Other Microarray
  • End-user
    • Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Other End Users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Merck KGaA (Germany)
  • PerkinElmer, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Qiagen N.V. (Netherlands)
  • GE Healthcare (United Kingdom)
  • Eurofins Scientific (Luxembourg)
  • Fluidigm Corporation (United States)
  • Oxford Gene Technology (United Kingdom)
  • Arrayit Corporation (United States)
  • Applied Micro Arrays (United States)
  • Phalanx Biotech Group (Taiwan)
  • LC Sciences (United States)
  • Savyon Diagnostics (Israel)
  • Progenika Biopharma (Spain)
  • Illuminomics Corporation (United States)
  • Sengenics (Singapore)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Microarray Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Microarray Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Microarray Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Microarray Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Microarray Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Microarray Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Microarray Market size was valued at USD 3.9 billion in 2021 and is poised to grow from USD 4.53 billion in 2023 to USD 7.67 billion by 2030, at a CAGR of 7.8% during the forecast period (2023-2030).

The competitive landscape of the microarray market is characterized by the presence of several key players operating globally and regionally. These companies focus on product development, strategic collaborations, and acquisitions to strengthen their market position. These companies invest significantly in research and development to introduce innovative microarray solutions and expand their product portfolios. They also engage in strategic partnerships and collaborations with academic institutions, research organizations, and pharmaceutical companies to enhance their market presence. With the growing demand for advanced genomic technologies, companies in the microarray market are focusing on offering comprehensive solutions that provide accurate and reliable gene expression analysis, enabling researchers and clinicians to gain valuable insights into diseases and facilitate personalized medicine approaches. 'Thermo Fisher Scientific Inc. (United States)', 'Illumina, Inc. (United States)', 'Agilent Technologies, Inc. (United States)', 'Merck KGaA (Germany)', 'PerkinElmer, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Qiagen N.V. (Netherlands)', 'GE Healthcare (United Kingdom)', 'Eurofins Scientific (Luxembourg)', 'Fluidigm Corporation (United States)', 'Oxford Gene Technology (United Kingdom)', 'Arrayit Corporation (United States)', 'Applied Micro Arrays (United States)', 'Phalanx Biotech Group (Taiwan)', 'LC Sciences (United States)', 'Savyon Diagnostics (Israel)', 'Progenika Biopharma (Spain)', 'Illuminomics Corporation (United States)', 'Sengenics (Singapore)'

The continuous advancements in genomic research and the increasing understanding of the genetic basis of diseases have fueled the demand for microarray technology. Microarrays enable researchers to analyze large sets of genetic information simultaneously, facilitating the identification of disease markers, gene expression patterns, and potential therapeutic targets.

The microarray market is witnessing several key market trends. Firstly, there is a growing demand for personalized medicine and precision diagnostics, which is driving the adoption of microarray technology for genetic analysis and profiling. This is fueled by advancements in genomics research and an increasing understanding of the role of genetic variations in disease susceptibility and treatment response. Secondly, there is a shift towards multiplexing and high-throughput analysis, with the development of microarrays capable of simultaneously analyzing thousands of genes or proteins. This enables researchers to obtain comprehensive data in a more efficient and cost-effective manner. Additionally, there is a rising focus on biomarker discovery and validation, as microarrays are being utilized to identify and validate potential biomarkers for various diseases, aiding in early detection and targeted therapies.

In 2021, North America emerged as the leading region in terms of revenue share in the microarray market, and this dominance is expected to persist until 2031. Several factors contribute to North America's continued prominence in the market. Firstly, the region benefits from a large patient population, which drives the demand for advanced diagnostic and research tools like microarray technology.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Microarray Market

Product ID: SQMIG35A2595

$5,300
BUY NOW GET FREE SAMPLE